Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Petty

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2014
Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatmentJeremy M Kilburn, Jeffrey G Kuremsky, A William Blackstock, et al.
Journal of Clinical Pharmacology|June 19, 2013
Placebo- and amitriptyline-controlled evaluation of central nervous system effects of the NK1 receptor antagonist aprepitant and intravenous alcohol infusion at pseudo-steady stateErik T te Beek, Daniel Tatosian, Anup Majumdar, et al.
Journal of the American Chemical Society|July 24, 2019
Engineering Molecular Ligand Shells on Quantum Dots for Quantitative Harvesting of Triplet Excitons Generated by Singlet FissionJesse R Allardice, Arya Thampi, Simon Dowland, et al.
Clinical Pharmacokinetics|May 25, 2005
Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitantArthur J Bergman, Thomas Marbury, Trisha Fosbinder, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjectsYanli Zhuang, Zhenhua Xu, Dick E de Vries, et al.
The Journal of Infectious Diseases|May 20, 2015
E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant RecipientArnaud G L'Huillier, Yacine Abed, Tom J Petty, et al.
Clinical Pharmacology and Therapeutics|August 2, 2003
Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probeAnup K Majumdar, Jacqueline B McCrea, Deborah L Panebianco, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2005
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patientsPeter Nygren, Kenneth Hande, Kevin J Petty, et al.
Journal of Clinical Pharmacology|April 28, 2007
Effect of aprepitant on the pharmacokinetics of intravenous midazolamAnup K Majumdar, Kerri X Yan, Diana V Selverian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancerJeremy M Kilburn, Scott C Lester, John T Lucas, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2014
Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatmentJeremy M Kilburn, Jeffrey G Kuremsky, A William Blackstock, et al.
Journal of Clinical Pharmacology|June 19, 2013
Placebo- and amitriptyline-controlled evaluation of central nervous system effects of the NK1 receptor antagonist aprepitant and intravenous alcohol infusion at pseudo-steady stateErik T te Beek, Daniel Tatosian, Anup Majumdar, et al.
Journal of the American Chemical Society|July 24, 2019
Engineering Molecular Ligand Shells on Quantum Dots for Quantitative Harvesting of Triplet Excitons Generated by Singlet FissionJesse R Allardice, Arya Thampi, Simon Dowland, et al.
Clinical Pharmacokinetics|May 25, 2005
Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitantArthur J Bergman, Thomas Marbury, Trisha Fosbinder, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjectsYanli Zhuang, Zhenhua Xu, Dick E de Vries, et al.
The Journal of Infectious Diseases|May 20, 2015
E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant RecipientArnaud G L'Huillier, Yacine Abed, Tom J Petty, et al.
Clinical Pharmacology and Therapeutics|August 2, 2003
Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probeAnup K Majumdar, Jacqueline B McCrea, Deborah L Panebianco, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2005
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patientsPeter Nygren, Kenneth Hande, Kevin J Petty, et al.
Journal of Clinical Pharmacology|April 28, 2007
Effect of aprepitant on the pharmacokinetics of intravenous midazolamAnup K Majumdar, Kerri X Yan, Diana V Selverian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancerJeremy M Kilburn, Scott C Lester, John T Lucas, et al.
Pageof 18